Clinical Trials Directory

Trials / Completed

CompletedNCT03343314

Effective Management of Calcific Aortic Stenosis in the Elderly

Status
Completed
Phase
Study type
Observational
Enrollment
1,101 (actual)
Sponsor
French Cardiology Society · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

Although aortic valve replacement is recommended for any symptomatic severe calcific aortic stenosis, the therapeutic decision may be difficult. because of patient age and comorbidities. Transcatheter Aortic Valve Implantation (TAVI) has recently extended the therapeutic indications in patients at high risk of surgery. However, the proportion of different treatments is not known in a contemporary population that can be treated according to the different resources currently available. The scientific goal of this observational research is to evaluate intra-hospital therapeutic decision in elderly patients referred because of symptomatic severe aortic stenosis. The one-year survival will be analyzed according to the therapeutic decision and the characteristics of the patients.

Conditions

Timeline

Start date
2016-09-01
Primary completion
2017-04-01
Completion
2018-12-01
First posted
2017-11-17
Last updated
2019-08-07

Source: ClinicalTrials.gov record NCT03343314. Inclusion in this directory is not an endorsement.